Neonatal Exposure to the Dipeptidyl Peptidase-IV Inhibitors Diprotin A and Sitagliptin Induces Depression-Like Behavior, Anxiety, and Latent Aggression in Adolescent and Adult Rats — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Neonatal Exposure to the Dipeptidyl Peptidase-IV Inhibitors Diprotin A and Sitagliptin Induces Depression-Like Behavior, Anxiety, and Latent Aggression in Adolescent and Adult Rats
Laboratory of the General Pathology of Nervous System, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology”, Moscow, Russia
,
Laboratory of the General Pathology of Nervous System, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology”, Moscow, Russia
1 Laboratory of the General Pathology of Nervous System, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology”, Moscow, Russia
2 Laboratory of the General Pathology of Nervous System, Federal State Budgetary Scientific Institution “Institute of General Pathology and Pathophysiology”, Moscow, Russia
Emotional and motivational disorders in adults are often considered to be the result of altered neurodevelopment. Clinical and experimental data provide evidence that serine protease dipeptidyl peptidase-IV (DPP-IV, EC 3.4.14.5) is involved in the pathophysiology of psycho-emotional disorders. Recently, we have shown that adolescent and adult rats exhibit an increase in anxiety and depression-related behaviors after neonatal administration of a synthetic non-competitive inhibitor of DPP-IV, methionyl-2(S)-cyano-pyrrolidine. In the present study, we tested the effects of two competitive, selective DPP-IV inhibitors, sitagliptin (4 mg/kg) and diprotin A (2 mg/kg), administered at postnatal days 5 - 18 on the emotional and motivational behavior of adolescent and adult rats. We observed increased anxiety in one-month-old diprotin A- or sitagliptin-treated rats in the elevated plus maze; diprotin A also enhanced the animals’ anxiety score using a ranked scale for evaluating anxiety and phobias. In the sucrose consumption and preference test, depressive-like behavior was pronounced in both the diprotin A- and sitagliptin-treated one-month-old animals, while only the diprotin A-treated rats exhibited a decrease in sucrose consumption at the age of 2 months. The diprotin A-treated rats also demonstrated behavioral despair and decreased activity in the forced swimming test within 1 - 3 months of age. Increased aggression was observed in 1 - 3-month-old diprotin A-treated rats and in two-month-old sitagliptin-treated rats. These findings support the hypothesis that DPP-IV is involved in the genesis of emotional and motivational disorders. Additionally, the results show that diprotin А impairs the adolescent and adult rats’ behavior more significantly than sitagliptin when the animals were treated with the DPP-IV inhibitors in the early postnatal period.
KeywordsDipeptidyl Peptidase IV InhibitorsRatDepressionAnxietyAggression
Millan, M.J. (2006) Multi-Target Strategies for the Improved Treatment of Depressive States: Conceptual Foundations and Neuronal Substrates, Drug Discovery and Therapeutic Application. Pharmacology & Therapeutics, 110, 135-370. http://dx.doi.org/10.1016/j.pharmthera.2005.11.006
Lasoń, W., Budziszewska, B., Basta-Kaim, A., Kubera, M. and Maes, M. (2013) New Trends in the Neurobiology and Pharmacology of Affective Disorders. Pharmacological Reports, 65, 1441-1450. http://dx.doi.org/10.1016/S1734-1140(13)71504-4
Chioqueta, A.P. and Stiles, T.C. (2003) Suicide Risk in Outpatients with Specific Mood and Anxiety Disorders. Crisis, 24, 105-112. http://dx.doi.org/10.1027//0227-5910.24.3.105
Kohn, S.R. and Asnis, G. M. (2003) Aggression in Psychiatric Disorders. In: Mattson, M.P., Ed., Neurobiology of Aggression: Understanding and Preventing Violence. Humana Press Inc., Totowa, NJ, 135-149. http://dx.doi.org/10.1385/1-59259-382-8:135
Neumann, I.D., Veenema, A.H. and Beiderbeck, D.I. (2010) Aggression and Anxiety: Social Context and Neurobiological Links. Frontiers in Behavioral Neuroscience, 4, 12.
(2013) American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 5th Edition, DSM-5TM, American Psychiatric Publishing, Arlington, VA. http://dsm.psychiatryonline.org/
Swann, A.C. (2003) Neuroreceptor Mechanisms of Aggression and its Treatment. The Journal of Clinical Psychiatry, 64, 26-35. http://www.psychiatrist.com/JCP/article/Pages/2003/v64s04/v64s0404.aspx
Villanueva, R. (2013) Neurobiology of Major Depressive Disorder. Neural Plasticity, 2013, Article ID: 873278, 7 p.
Martin, E.I., Ressler, K.J., Binder, E. and Nemeroff C.B. (2009) The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psycho-neuroendocrinology. Psychiatric Clinics of North America, 32, 549-575. http://dx.doi.org/10.1016/j.psc.2009.05.004
Siever, L.J. (2008) Neurobiology of Aggression and Violence. The American Journal of Psychiatry, 165, 429-442. http://dx.doi.org/10.1176/appi.ajp.2008.07111774
Yanowitch, R. and Coccaro, E.F. (2011) Chapter 7—The Neurochemistry of Human Aggression. Advances in Genetics, 75, 151-169. http://dx.doi.org/10.1016/B978-0-12-380858-5.00005-8
Patki, G., Atrooz, F., Alkadhi, I., Solanki, N. and Salim, S. (2015) High Aggression in Rats Is Associated with Elevated Stress, Anxiety-Like Behavior, and Altered Catecholamine Content in the Brain. Neuroscience Letters, 584, 308-313. http://dx.doi.org/10.1016/j.neulet.2014.10.051
Walker, A.J., Kim, Y., Price, J.B., Kale, R.P., McGillivray, J.A., Berk, M. and Tye, S.J. (2014) Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention. Frontiers in Psychiatry, 5, 34. http://dx.doi.org/10.3389/fpsyt.2014.00034
Heim, C., Plotsky, P.M. and Nemeroff, C.B. (2004) Importance of Studying the Contributions of Early Adverse Experience to Neurobiological Findings in Depression. Neuropsycho-pharmacology, 29, 641-648. http://dx.doi.org/10.1038/sj.npp.1300397
Hansson, S.R., Hoffman, B.J. and Mezey, E. (1998) Ontogeny of Vesicular Monoamine Transporter mRNAs VMAT1 and VMAT2. I. The Developing Rat Central Nervous System. Developmental Brain Research, 110, 135-158. http://dx.doi.org/10.1016/S0165-3806(98)00104-7
Ugryumov, M.V. (2000) The Differentiation of Dopaminergic Neurons in Situ, in Vivo, and in Transplants. Neuroscience and Behavioral Physiology, 30, 37-43. http://dx.doi.org/10.1007/BF02461390
Shabanov, P.D., Lebedev, A.A. and Nozdrachev, A.D. (2002) Critical Periods of the Dopaminergic System Formation in Rat Brain. Doklady Biological Sciences, 386, 421-425. http://dx.doi.org/10.1023/A:1020758100186
Catena-Dell’Osso, M., Fagiolini, A., Marazziti, D., Baroni, S. and Bellantuono, C. (2013) Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides. Mini Reviews in Medicinal Chemistry, 13, 2-10. http://dx.doi.org/10.2174/138955713804484758
Díaz, C., Morales-Delgado, N. and Puelles, L. (2015) Ontogenesis of Peptidergic Neurons within the Genoarchitectonic Map of the Mouse Hypothalamus. Frontiers in Neuroanatomy, 8, 162.
Vanhoof, G., Goossens, F., De Meester, I., Hendriks, D. and Scharpé, S. (1995) Proline Motifs in Peptides and Their Biological Processing. Federation of American Societies for Experimental Biology Journal, 9, 736-744. http://www.fasebj.org/content/9/9/736.full.pdf
Maes, M. and Bonaccorso, S. (2004) Lower Activities of Serum Peptidases Predict Higher Depressive and Anxiety Levels Following Interferon-Alpha-Based Immunotherapy in Patients with Hepatitis C. Acta Psychiatrica Scandinavica, 109, 126-131. http://dx.doi.org/10.2174/138955713804484758
Deng, J., Lamb, J.R., McKeown, A.P., Miller, S., Muglia, P., Guest, P.C., Bahn, S., Domenici, E.H. and Rahmoune, H. (2013) Identification of Altered Dipeptidyl-Peptidase Activities as Potential Biomarkers for Unipolar Depression. Journal of Affective Disorders, 151, 667-672. http://dx.doi.org/10.1016/j.jad.2013.07.015
El Yacoubi, M., Vaugeois, J., Marguet, D., Sauze, N., Guieu, R., Costentin, J. and Fenouillet, E. (2006) Behavioral Characterization of CD26 Deficient Mice in Animal Tests of Anxiety and Antidepressant-Like Activity. Behavioural Brain Research, 171, 279-285. http://dx.doi.org/10.1016/j.bbr.2006.04.003
Frerker, N., Raber, K., Bode, F., Skripuletz, T., Nave, H., Klemann, C., Pabst, R., Stephan, M., Schade, J., Brabant, G., Wedekind, D., Jacobs, R., Jorns, A., Forssmann, U., Straub, R.H., Johannes, S., Hoffmann, T., Wagner, L., Demuth, H.U. and von Horsten, S. (2009) Phenotyping of Congenic Dipeptidyl Peptidase 4 (DP4) Deficient Dark Agouti (DA) Rats Suggests Involvement of DP4 in Neuro-, Endocrine, and Immune Functions. Clinical Chemistry and Laboratory Medicine, 47, 275-287. http://dx.doi.org/10.1515/CCLM.2009.064
Krupina, N.A., Zolotov, N.N., Bogdanova, N.G., Orlova, I.N., Khlebnikova, N.N. and Kryzhanovskii, G.N. (2006) Activities of Prolyl Endopeptidase and Dipeptidyl Peptidase IV in Brain Structures of Rats with Dopamine Deficiency-Dependent MPTP-Induced Depressive Syndrome. Bulletin of Experimental Biology and Medicine, 142, 554-556. http://dx.doi.org/10.1007/s10517-006-0416-5
Krupina, N.A., Bogdanova, N.G., Khlebnikova, N.N., Zolotov, N.N. and Kryzhanovskii, G.N. (2013) Benzyloxycarbon-yl-methionyl-2(S)-cyanopyrrolidine, a Prolyl Endopeptidase Inhibitor, Modulates Depression-Like Behavior of Rats in Forced Swimming Test and Activities of Proline-Specific Peptidases in the Brain Structures. Bulletin of Experimental Biology and Medicine, 154, 606-609. http://dx.doi.org/10.1007/s10517-013-2010-y
Kato, T., Hama, T., Nagatsu, T., Kuzuya, Y. and Sakakibara, S. (1979) Changes of X-Prolyl Dipeptidyl-Aminopeptidase Activity in Developing Rat Brain. Experientia, 35, 1329-1330. http://dx.doi.org/10.1007/bf01963989 http://link.springer.com/article/10.1007/BF01963989
Brust, P., Bech, A., Kretzschmar, R. and Bergmann, R. (1994) Developmental Changes of Enzymes Involved in Peptide Degradation in Isolated Rat Brain Microvessels. Peptides, 15, 1085-1088. http://dx.doi.org/10.1016/0196-9781(94)90074-4
Krupina, N.A., Kushnareva, E.Y., Khlebnikova, N.N., Zolotov, N.N. and Kryzhanovskii, G.N. (2009) Behavioral Changes in Rats Induced by a Dipeptidyl Peptidase IV Inhibitor Methionyl-2(S)-cyanopyrrolidine: Experimental Model of Anxiety-Depression Disorder. Bulletin of Experimental Biology and Medicine, 147, 285-290. http://dx.doi.org/10.1007/s10517-009-0493-3
Khlebnikova, N.N., Kushnareva, E.Y., Krupina, N.A. and Rodina, V.I. (2011) Novel Synthetic Inhibitor of Dipeptidyl Peptidase IV Methionyl-2(S)-cyanopyrrolidine Induces Latent Aggression in Rats. European Neuropsychopharmacology, 21, S302. http://dx.doi.org/10.1016/s0924-977x(11)70477-1
Khlebnikova, N.N., Krupina, N.A., Kushnareva, E.Y., Zolotov, N.N. and Kryzhanovskii, G.N. (2012) Effect of Imipramine and Prolyl Endopeptidase Inhibitor Ben-zyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine on Activity of Proline-Specific Peptidases in the Brain of Rats with Experimental Anxious-Depressive Syndrome. Bulletin of Experimental Biology and Medicine, 152, 409-412. http://dx.doi.org/10.1007/s10517-012-1540-z
McIntosh, C.H., Demuth, H.U., Kim, S.J., Pospisilik, J.A. and Pederson, R.A. (2006) Applications of Dipeptidyl Peptidase IV Inhibitors in Diabetes Mellitus. International Journal of Biochemistry and Cell Biology, 38, 860-872. http://dx.doi.org/10.1016/j.biocel.2005.12.013
Hsieh, C.J. and Shen, F.C. (2014) The Durability of Sitagliptin in Elderly Patients with Type 2 Diabetes. Clinical Interventions in Aging, 9, 1905-1911. http://dx.doi.org/10.2147/CIA.S72396
Broxmeyer, H.E. and Pelus, L.M. (2014) Inhibition of DPP4/CD26 and dmPGE2 Treatment Enhances Engraftment of Mouse Bone Marrow Hematopoietic Stem Cells. Blood Cells, Molecules, and Diseases, 53, 34-38. http://dx.doi.org/10.1016/j.bcmd.2014.02.002
Guskova, T.A. (2010) Preclinical Toxicological Study of Drugs as a Guarantee of Their Safe Clinical Investigations. Toksikologicheski Vestnik, 5, 2-5. http://en.toxreview.ru/magazine/?c4a=20100500
Walf, A.A. and Frye, C.A. (2007) The Use of the Elevated plus Maze as an Assay of Anxiety-Related Behavior in Rodents. Nature Protocols, 2, 322-328. http://dx.doi.org/10.1038/nprot.2007.44
Ennaceur, A. (2014) Tests of Unconditioned Anxiety—Pitfalls and Disappointments. Physiology and Behavior, 135, 55-71. http://dx.doi.org/10.1016/j.physbeh.2014.05.032
O’Leary, T.P., Gunn, R.K. and Brown, R.E. (2013) What Are We Measuring When We Test Strain Differences in Anxiety in Mice? Behavior Genetics, 43, 34-50.
Estanislau, C. (2012) Cues to the Usefulness of Grooming Behavior in the Evaluation of Anxiety in the Elevated Plus-Maze. Psychology & Neuroscience, 5, 105-112. http://dx.doi.org/10.3922/j.psns.2012.1.14
Porsolt, R.D., Anton, G., Blavet, N. and Jalfre, M. (1978) Behavioral Despair in Rats: A New Model Sensitive to Antidepressant Treatments. European Journal of Pharmacology, 47, 379-391. http://dx.doi.org/10.1016/0014-2999(78)90118-8
Overstreet, D.H., Pucilowski, O., Rezvani, A.H. and Janowsky, D.S. (1995) Administration of Antidepressants, Diazepam and Psychomotor Stimulants Further Confirms the Utility of Flinders Sensitive Line Rats as an Animal Model of Depression. Psychopharmacology, 121, 27-37. http://dx.doi.org/10.1007/BF02245589
Kryzhanovskii, G.N., Krupina, N.A. and Kucheryanu, V.G. (1995) A New Model of the Depressive Syndrome Induced by Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Rats. Bulletin of Experimental Biology and Medicine, 119, 116-119. http://dx.doi.org/10.1007/BF02445853
Shchetinin, E.V., Baturin, V.A., Arushanian, E.B., Ovanesov, K.B. and Popov, A.V. (1989) A Biorhythmologic Approach to Evaluating Forced Swimming as an Experimental Model of a “Depressive” State. Zhurnal Vysshei Nervnoi Deiatelnosti imeni IP Pavlova, 39, 958-964. http://elibrary.ru/item.asp?id=19109145
Rodina, V.I., Krupina, N.A., Kryzhanovskii, G.N. and Oknina, N.B. (1992) A New Method of Evaluating Anxiety States and Phobias in Rats. Bulletin of Experimental Biology and Medicine, 114, 916-920. http://dx.doi.org/10.1007/BF00790041
D’Aquila, P.S., Newton, J. and Willner, P. (1997) Diurnal Variation in the Effect of Chronic Mild Stress on Sucrose Intake and Preference. Physiology and Behavior, 62, 421-426. http://dx.doi.org/10.1016/S0031-9384(97)00042-5
Benjamini, Y. and Hochberg, Y. (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological), 57, 289-300. http://www.jstor.org/stable/2346101
Kushnareva, E.Y., Krupina, N.A., Khlebnikova, N.N., Kudrin, V.S., Zolotov, N.N. and Kryzhanovskii, G.N. (2012) The Levels of Monoamines and Their Metabolites in the Brain Structures of Rats with an Experimental Anxiodepressive State Induced by Administration of Dipeptidyl Peptidase 4 in the Early Postnatal Period. Neurochemical Journal, 6, 29-37. http://dx.doi.org/10.1134/S1819712412010047
Chakraborty, C., Hsu, M.J. and Agoramoorthy, G. (2014) Understanding the Molecular Dynamics of Type-2 Diabetes Drug Target DPP-4 and Its Interaction with Sitagliptin and Inhibitor Diprotin-A. Cell Biochemistry and Biophysics, 70, 907-922. http://dx.doi.org/10.1007/s12013-014-9998-0
File, S.E. and Seth, P. (2003) A Review of 25 Years of the Social Interaction Test. European Journal of Pharmacology, 463, 35-53. http://dx.doi.org/10.1016/S0014-2999(03)01273-1
Gault, V.A., Lennox, R. and Flatt, P.R. (2015) Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Recognition Memory, Oxidative Stress and Hippocampal Neurogenesis and Upregulates Key Genes Involved in Cognitive Decline. Diabetes, Obesity and Metabolism, 17, 403-413. http://dx.doi.org/10.1111/dom.12432
Karl, T., Hoffmann, T., Pabst, R. and von Horsten, S. (2003) Extreme Reduction of Dipeptidyl Peptidase IV Activity in F344 Rat Substrains is Associated with Various Behavioral Differences. Physiology and Behavior, 80, 123-134. http://dx.doi.org/10.1016/S0031-9384(03)00229-4
Van West, D., Monteleone, P., Di Lieto, A., De Meester, I., Durinx, C., Scharpe, S., Lin, A., Maj, M. and Maes, M. (2000) Lowered Serum Dipeptidyl Peptidase IV Activity in Patients with Anorexia and Bulimia Nervosa. European Archives of Psychiatry and Clinical Neuroscience, 250, 86-92. http://dx.doi.org/10.1007/s004060070040
Scharpé, S. and De Meester, I. (2001) Peptide Truncation by Dipeptidyl Peptidase IV: A New Pathway for Drug Discovery? Verhandelingen-Koninklijke Vlaamse Academie voor Geneeskunde van Belgie, 63, 5-32.
Haller, J. (2013) The Neurobiology of Abnormal Manifestations of Aggression—A Review of Hypothalamic Mechanisms in Cats, Rodents, and Humans. Brain Research Bulletin, 93, 97-109. http://dx.doi.org/10.1016/j.brainresbull.2012.10.003
Sharma, A.N., Pise, A., Sharma, J.N. and Shukla, P. (2015) Dipeptidyl-Peptidase IV (DPP-IV) Inhibitor Delays Tolerance to Anxiolytic Effect of Ethanol and Withdrawal-Induced Anxiety in Rats. Metabolic Brain Disease, 30, 659-667. http://dx.doi.org/10.1007/s11011-014-9603-7